|
|
| (14 intermediate revisions not shown) |
| Line 3: |
Line 3: |
| | <br /> | | <br /> |
| | <h1>Parts</h1> | | <h1>Parts</h1> |
| - | The 2011 University of Glasgow team has submitted 9 novel biobricks. You can find out more about these below, or by visiting the Registry Page. If you are interested in finding out about the safety reviews of these biobricks then please visit our Biobrick Safety Page, which can be accessed <a href="https://2011.igem.org/Team:Glasgow/Safetybiobricks">here.</a> <br/> | + | The 2011 University of Glasgow team has submitted a number of novel biobricks, ranging from reporters with more functionality than GFP to our novel biofilm chassis. You can find out more about these by using the links below. <br/><Br/><br/><Br/> |
| | + | |
| | + | <center> |
| | + | |
| | + | <a href=https://2011.igem.org/Team:Glasgow/PDE>Phosphodiesterase</a><br/> |
| | + | <a href=https://2011.igem.org/Team:Glasgow/mcs>Multiple Cloning Site</a><br/> |
| | + | <a href=https://2011.igem.org/Team:Glasgow/LOV2>LOV2 and iLOV</a><br/> |
| | + | <a href=https://2011.igem.org/Team:Glasgow/Parts/Latherin>Latherin</a><br/> |
| | + | <a href=https://2011.igem.org/Team:Glasgow/Ranaspumin2>Ranaspumin-2</a><br/> |
| | + | <a href=https://2011.igem.org/Team:Glasgow/Nissle><i>E.coli</i> Nissle 1917</a></td> |
| | + | <br/<br/><br/> |
| | + | <img src=https://static.igem.org/mediawiki/2011/thumb/2/27/Lovlleaf-pola-annotated.jpg/493px-Lovlleaf-pola-annotated.jpg width=250 height=250> |
| | + | <img src=https://static.igem.org/mediawiki/2011/thumb/5/55/Untitled-pola-annotated.jpg/493px-Untitled-pola-annotated.jpg width=275 height=275> |
| | + | <br/><br/><br/><br/><br/> |
| | + | Alternatively, to visit the Registry page for each of our biobricks, please use the table below. <br/><br/> If you are interested in finding out about the safety reviews of these biobricks then please visit our Biobrick Safety Page, which can be accessed <a href="https://2011.igem.org/Team:Glasgow/Safetybiobricks">here.</a> <br/> |
| | </html> | | </html> |
| | | | |
| Line 10: |
Line 24: |
| | <br/> | | <br/> |
| | <html> | | <html> |
| - | <h1>Phosphodiesterase</h1> | + | <center> |
| - | | + | |
| - | <b>Phosphodiesterase (<a href="http://partsregistry.org/Part:BBa_K660300">Part BBa_K660300</a>)<br/><br/></b>
| + | |
| - | | + | |
| - | Phosphodiesterases are a family of enzymes naturally present in microorganisms, which break phosphodiester bonds. The specific enzyme we are using breaks the phosphodiester bond in the second messenger nucleotide, cyclic digaunylate (cyclic-di-GMP). Cyclic-di-GMP is important in many bacterial processes, including biofilm formation and motility. The enzyme regulates signal transduction by controlling levels of the signalling molecule in cells. This approach of quenching the c-di-GMP signal has been shown to disperse biofilm.1<br/><br/>
| + | |
| - | | + | |
| - | This enzyme was amplified from the genome of <i>Pseudomonas aeruginosa</i> PA01. The enzyme contains a domain (vieA) which specifically targets the cyclic-di-GMP molecule.
| + | |
| - | | + | |
| - | We are using the enzyme to control the levels of cyclic-di-GMP within the cell. We expect that the targeted expression of phosphodesiterase could be used to interfere with biofilm formation or to trigger dispersal.<br/><br/>
| + | |
| - | Due to the number of processes in which cyclic-di-GMP is used by prokarytes, we hope that future iGEM teams will find diverse uses for it.<br/><br/>
| + | |
| - | | + | |
| - | <b>References & Further Reading:</b><br/><br/>
| + | |
| - | "The EAL Domain Protein VieA Is a Cyclic Diguanylate Phosphodiesterase" which can be accessed here <a href="http://www.jbc.org/content/280/39/33324.abstract">here.</a><br /><br />
| + | |
| - | | + | |
| - | "A blue light-inducible phosphodiesterase activity in the cyanobacterium <i>Synechococcus elongates</i>" which can be accessed <a href="http://www.ncbi.nlm.nih.gov/pubmed/20408974">here.</a></br></br>
| + | |
| - | | + | |
| - | "Engineering a novel c-di-GMP-binding protein for biofilm dispersal" which can be accessed <a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1462-2920.2010.02368.x/abstract">here.</a>
| + | |
| - | | + | |
| - | <h1>Multiple Cloning Site (MCS) Biobrick</h1> <p>(<a href="http://partsregistry.org/Part:BBa_K660500">Part:BBa_K660500</a>)
| + | |
| - | | + | |
| - | <p>We wanted to test multiple genes with the same promoter, RBS and terminator to characterise PDE, latherin, latherin with HIS tag, ranaspumin-2 and ranaspumin-2 with HIS tag , which are some of our novel biobricks. To ligate one of these constructs together requires three or four (three if you’re using the 3A method) restriction and ligation reactions. So to test all five under the same promoter, RBS and terminator would require at the very least 15 restriction and ligation reactions. However using our multiple cloning site (MCS) biobrick it is possible to create the promoter, RBS, MCS and terminator construct in three-four ligations before inserting each gene into the MCS with just one extra restriction and ligation step. So it would be possible to have all five constructs made in just nine restriction and ligation reactions, saving a huge amount of time. And for each extra gene you want to test this would only require one extra restriction and ligation rather than three or four. This is great for characterisation of a large number of biobricks. We suggest that if you plan to use the MCS biobrick, when you are adding biobrick ends to your PCR primers or sequence for synthesis , add one of the restriction sites included in our MCS before and after the whole construct. As long as you ensure the gene is still in-frame then you can easily insert it into your standard construct for testing. When it comes to submission, just restrict the novel biobrick out of the characterisation construct and into ligate your submission vector . Restricting with X+S only just your gene will drop out. Restricting with E+P will give fragments for your promoter+ RBS and terminator as well as your gene however the gene will usually be much larger than the fragments allowing for gel purification of only the restricted gene.<p>
| + | |
| - | | + | |
| - | <div align="center">
| + | |
| - | <img src="https://static.igem.org/mediawiki/2011/1/10/GlasgowMCSbiobrick.jpg" />
| + | |
| - | <img src="https://static.igem.org/mediawiki/2011/5/5b/MCStable.jpg" width="395" height="188" />
| + | |
| - | </div>
| + | |
| - | <h1>Novel Reporters</h1>
| + | |
| - | | + | |
| - | We have submitted two novel reporters to the registry, LOV2 and iLOV. Read on to find out about the exciting advantages these reporters have over GFP derived flourescent proteins. <br/><br/>
| + | |
| - | | + | |
| - | <b>LOV2 (<a href="http://partsregistry.org/Part:BBa_K660000">Part:BBa_K660000</a>)<br/><br/></b>
| + | |
| - | The LOV (Light-Oxygen-Voltage) domain is a photoreceptor that responds to blue light. In nature it was first found to be involved in the phototropism response in plants and has since been found to be present in fungi and bacteria also. It has been shown to be coupled to many domains, for example phosphodiesterase or kinases.
| + | |
| - | <br/><br/>
| + | |
| - | We are using it as a reporter due to its ability to function in anoxic conditions. This is particularly useful in biofilms and is a function that fluorescent proteins derived from GFP do not have.
| + | |
| - | <br/><br/>
| + | |
| - | <b>iLOV (<a href="http://partsregistry.org/Part:BBa_K660004">Part:BBa_K660004</a>)</b>
| + | |
| - | <br/><br/>
| + | |
| - | iLOV is a version of LOV2 that has been altered through site directed mutagenesis and DNA shuffling. iLOV has the same function and uses as LOV2, but contains mutations that caused increased intensity in brightness.<br/><Br/>
| + | |
| - | | + | |
| - | As a reporter, it is advantageous over GFP derived fluorescent proteins for a number of reasons. Firstly, it is small in size so can be used when tagging proteins. It also recovers quickly from photobleaching. Uniquely, it has the ability to function in anoxic conditions.
| + | |
| - | <br/><br/>
| + | |
| - | <b>References & Further Reading:</b><br/><br/>
| + | |
| - | "LOV (light, oxygen, or voltage) domains of the blue-light photoreceptor phototropin (nph1): Binding sites for the chromophore flavin mononucleotide" which can be accessed <a href="http://www.pnas.org/content/96/15/8779.short">here.</a><br /><br />
| + | |
| - | "The LOV Domain Family: Photoresponsive Signaling Modules Coupled to Diverse Output Domains" which can be accessed <a href="http://pubs.acs.org/doi/abs/10.1021/bi026978l">here.</a><br /><br />
| + | |
| - | "Information on the LOV Domain" by Dr John Christie which can be accessed <a href="http://www.photobiology.info/Christie.html">here.</a><Br /><br/>
| + | |
| - | "The photoreversible fluorescent protein iLOV outperforms GFP as a reporter of plant virus infection" which can be accessed <a href="http://www.pnas.org/content/105/50/20038.short">here.</a><br/>
| + | |
| - | | + | |
| - | <h1>Surfactant Proteins</h1>
| + | |
| - | | + | |
| - | We have developed biobricks of surfactant proteins, Ranaspumin and Latherin, which have been investigated for their antimicrobial activity.
| + | |
| - | <br/><br/>
| + | |
| - | <b>Ranaspumin-2 (RSN2) (<a href="http://partsregistry.org/Part:BBa_K660100">Part:BBa_K660100</a>)</b>
| + | |
| - | <br/><br/>
| + | |
| - | Ranaspumin-2 is a protein found in the foam nests of the Túngara Frog <i>(Engystomops pustulosus).</i> In nature it is used to protect and incubate the fertilized eggs of the frog.<br/><Br/> It has natural antimicrobial and antibiofilm activity.<br/><br/>
| + | |
| - | | + | |
| - | Ranaspumin-2 has a <a href="http://www.cell.com/biophysj/abstract/S0006-3495%2809%2900792-9">unique amino acid sequence.</a>
| + | |
| - | <br/><br/>
| + | |
| - | <b>Ranspumin-2 (RSN2) with 6xHIS tag (<a href="http://partsregistry.org/Part:BBa_K660101">Part:BBa_K660101</a>)</b>
| + | |
| - | <br/><br/>
| + | |
| - | We have also created a version of Ranaspumin-2 (RSN2) biobrick with a 6xHIS tag. This can be used for affinity purification.
| + | |
| - | <br/><br/>
| + | |
| - | <b>References & Further Reading:</b>
| + | |
| - | <br/><br/>
| + | |
| - | <br/><br/>More information on Ranaspumin is available <a href=https://2011.igem.org/Team:Glasgow/Parts/Ranaspumin2>here</a>
| + | |
| - | | + | |
| - | </html>
| + | |
| - | | + | |
| - | "Ranaspumin-2: Structure and Function of a Surfactant Protein from the Foam Nests of a Tropical Frog" which can be accessed <a href="http://www.sciencedirect.com/science/article/pii/S0006349509007929">here.</a><br /><br />
| + | |
| - | | + | |
| - | "Biofoams and natural protein surfactants" which can be accessed <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954283/">here.</a>
| + | |
| - | <br/><br/>
| + | |
| - | <b>Latherin (<a href="http://partsregistry.org/Part:BBa_K660200">Part:BBa_K660200</a>)</b>
| + | |
| - | <br/><br/>More information on Latherin is available <a href=https://2011.igem.org/Team:Glasgow/Parts/Latherin>here</a>
| + | |
| - | | + | |
| - | </html>
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | <!---
| + | |
| - | ===Parts===
| + | |
| - | | + | |
| - | New for iGEM 2010 is the ''groupparts'' tag. This tag will generate a table with all of the parts that your team adds to your team sandbox. Note that if you want to document a part you need to document it on the [http://partsregistry.org Registry], not on your team wiki.
| + | |
| - | | + | |
| - | <groupparts>iGEM010 Glasgow</groupparts>
| + | |
| - | --->
| + | |
The 2011 University of Glasgow team has submitted a number of novel biobricks, ranging from reporters with more functionality than GFP to our novel biofilm chassis. You can find out more about these by using the links below.
"
